ecancer· @ecancer · X·· 14 小时前评分70
正文 · 原文
The phase II AMPLIFY-7P trial evaluated camupepimut (ELI-002 7P) in resected KRAS-mutated pancreatic cancer. Watch @EileenMOReilly discuss the trial 👉 https://bit.ly/4ihh55E #ESMO26
48 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
7P按 Proffered paper 1: Gastrointestinal tumour, upper digestive 对上
Proffered paper 1: Gastrointestinal tumour, upper digestive
https://esmocongress.esmo.org来源：ecancer · x.com